IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 25,250
-1,150 (-4.36%)
At close: Jun 5, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 379.3 billion as of June 8, 2026.
Market Cap
379.30B
Enterprise Value
362.10B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,250.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 379.30B, a decrease of -22.96%. That is a compound annual growth rate of -22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 379.30B | -55.95% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 624.03B |
| Curocell | 441.64B |
| IMBiologics | 411.55B |
| HansBiomed | 405.74B |
| S.Biomedics | 378.98B |
| curacle co.,ltd. | 283.34B |
| Kanaph Therapeutics | 278.88B |
| Kangstem Biotech | 247.83B |